Discontinued — last reported Q4 '25
Roivant Sciences Compensation and benefits increased by 63.7% to $82.18M in Q2 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase often reflects headcount growth or higher performance-based incentives, while a decrease may indicate efficiency initiatives or workforce reductions.
Includes all salaries, wages, bonuses, stock-based compensation, and employee benefit costs for the workforce. This is t...
Highly comparable across all sectors; usually found under 'Personnel' or 'Staffing' expenses.
compensation_and_benefits| Q2 '24 | Q2 '25 | |
|---|---|---|
| Value | $50.19M | $82.18M |
| QoQ Change | — | +63.7% |
| YoY Change | — | +63.7% |
| Segment | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|
| Reportable Segment | $70.83M | $86.87M | $69.52M |
| Total | — | — | — |